Immunomodulatory Role of Eosinophils in Determining Inflammation and Insulin Sensitivity in Human Adipose Tissue- Aims 1&2
The study conducted by Mayo Clinic investigates the immunomodulatory role of eosinophils in adipose tissue, particularly focusing on their relationship with inflammation and insulin sensitivity. Given the rising prevalence of obesity and insulin resistance globally, this research could have significant implications for developing therapeutic strategies targeting eosinophils to improve metabolic health. The findings may enhance the understanding of obesity-related inflammation and lead to potential dietary supplement interventions, such as fish oil, which could be marketed to consumers seeking to manage weight and metabolic health. The competitive landscape includes other obesity and insulin resistance therapies, but the unique focus on eosinophils may provide a novel angle for differentiation. Diligence should assess the potential for commercialization based on the study's outcomes and the regulatory pathway for any resultant products.
Indication: Obesity
Modality: RNA therapy
Target: Eosinophils in adipose tissue and their role in inflammation and insulin sensitivity.
Sponsor: Mayo Clinic
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 03, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Eosinophils in adipose tissue and their role in inflammation and insulin sensitivity.
View original source fields
Condition raw: Obesity, Insulin Resistance
Condition normalized: Obesity, Insulin Resistance
Modality raw: RNA therapy
Modality normalized: RNA therapy
Target raw: Eosinophils in adipose tissue and their role in inflammation and insulin sensitivity.
Target normalized: Eosinophils in adipose tissue and their role in inflammation and insulin sensitivity.